TAO Synergies TAOX
NASDAQ TAOX
$3.39 -0.15 (-4.37%)
As of: Oct 22, 2026 · 3:59 PM EDT

TAO Synergies (TAOX) Asset Utilization Ratio (2026)

Updated

TAO Synergies' Asset Utilization Ratio was 0.03 in Q2 2026, up 22.5% from the prior quarter.

Analysis

TAO Synergies (TAOX) Asset Utilization Ratio (2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at TAO Synergies came in at 0.01.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.62
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.50
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.47
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.52
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.46
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.51
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.40
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.58
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 TAO Synergies 25.11 Mn -836,888.78 - 0.03
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.03
Mar 31, 2026 0.02
API Access

TAO Synergies Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TAOX&period=max&api_key=YOUR_API_KEY